Jun 3 2024Breast Cancer Now
Breast Cancer Now has awarded £249,065 to Dr Stephen Robinson at the Quadram Institute to study the composition and function of the gut bacteria in oestrogen receptor positive breast cancer. The team will compare samples from people who respond well to treatment to people who don’t, to analyze any differences in their gut bacteria and see if it’s possible to predict the outcome of treatment based on this information.
“With around 11,500 women tragically dying from breast cancer each year in the UK, we urgently need to find new ways to prevent the disease spreading, and treat it effectively when it does.” After an ultrasound, mammogram and needle biopsy, Kerry was given the devastating news that she had grade 2, ER-positive breast cancer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breast Cancer Now funds new research to investigate how breast cancer cells survive and growResearchers in Sheffield are investigating how breast cancer cells survive and grow, thanks to new funding from Breast Cancer Now.
Source: NewsMedical - 🏆 19. / 71 Read more »
Norwich researchers examine gut bacteria and breast cancer linkThe charity Breast Cancer Now says it could help in the 'fight against the disease'.
Source: bbcemt - 🏆 120. / 51 Read more »
Researchers identify new marker for breast cancer prognosisA protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers identify what drives PARP inhibitor resistance in advanced breast cancerResearchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who's more likely to respond to these drugs, and could lead to more effective ways to treat the disease.
Source: medical_xpress - 🏆 101. / 51 Read more »
Oncotype DX Breast Recurrence Score test recommended by NICE for lymph node-positive breast cancer patientsExact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to more effectively target chemotherapy treatment for women who have hormone receptor-positive (HR+),...
Source: NewsMedical - 🏆 19. / 71 Read more »
Adiposity in childhood affects the risk of breast cancer by changing breast tissue composition, study suggestsBreast cancer is the most common cancer in women worldwide. With rates continuing to rise, there is an urgent need to identify new modifiable breast cancer risk factors. New research led by the University of Bristol suggests that higher adiposity in childhood leads to less dense breast tissue forming, which results in a reduced breast cancer risk.
Source: medical_xpress - 🏆 101. / 51 Read more »